121 related articles for article (PubMed ID: 38358906)
1. Mixing studies for lupus anticoagulant: does it matter how we mix?
Radišić Biljak V; Tomas M; Lapić I
Blood Coagul Fibrinolysis; 2024 Apr; 35(3):129-132. PubMed ID: 38358906
[TBL] [Abstract][Full Text] [Related]
2. Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing.
Cabo J; Morimont L; Baudar J; Guldenpfennig M; Jacqmin H; Soleimani R; Lecompte T; Douxfils J; Mullier F
Int J Lab Hematol; 2023 Feb; 45(1):126-136. PubMed ID: 36222181
[TBL] [Abstract][Full Text] [Related]
3. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
Ieko M; Naito S; Yoshida M
Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
[TBL] [Abstract][Full Text] [Related]
4. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
[TBL] [Abstract][Full Text] [Related]
5. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
[TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulant mixing studies and normalization of results how best to proceed.
Montaruli B; Bairo A; Beltrami E; Cabodi D; Muccini E; Papandrea M; Rolla R; Sampietro S; Valesella P; Sciascia S
Int J Lab Hematol; 2024 Feb; 46(1):183-189. PubMed ID: 37846783
[No Abstract] [Full Text] [Related]
7. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
[TBL] [Abstract][Full Text] [Related]
8. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
[TBL] [Abstract][Full Text] [Related]
9. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
[TBL] [Abstract][Full Text] [Related]
10. Mixing studies for lupus anticoagulant: mostly no, sometimes yes.
Moore GW
Clin Chem Lab Med; 2020 Mar; 58(4):492-495. PubMed ID: 31874095
[TBL] [Abstract][Full Text] [Related]
11. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.
Tripodi A; Chantarangkul V; Cini M; Devreese K; Dlott JS; Giacomello R; Gray E; Legnani C; Martinuzzo ME; Pradella P; Siegemund A; Subramanian S; Suchon P; Testa S
J Thromb Haemost; 2017 Jun; 15(6):1180-1190. PubMed ID: 28316135
[TBL] [Abstract][Full Text] [Related]
12. Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.
Esmedere Eren S; Karakukcu C; Ciraci MZ; Ustundag Y; Karakukcu M
Blood Coagul Fibrinolysis; 2018 Jun; 29(4):410-414. PubMed ID: 29708898
[TBL] [Abstract][Full Text] [Related]
13. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
[TBL] [Abstract][Full Text] [Related]
14. [Acquired coagulation disorders].
Suzuki N
Rinsho Ketsueki; 2020; 61(7):779-784. PubMed ID: 32759565
[TBL] [Abstract][Full Text] [Related]
15. Mixing studies in lupus anticoagulant testing are required at least in some type of samples.
Devreese KM; de Laat B
J Thromb Haemost; 2015 Aug; 13(8):1475-8. PubMed ID: 26017873
[TBL] [Abstract][Full Text] [Related]
16. Validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents.
Kumano O; Moore GW
Thromb Res; 2023 Nov; 231():39-43. PubMed ID: 37801773
[No Abstract] [Full Text] [Related]
17. APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N
J Thromb Haemost; 2012 Nov; 10(11):2338-43. PubMed ID: 22909048
[TBL] [Abstract][Full Text] [Related]
18. Lupus anticoagulant diagnosis in activated partial thromboplastin time mixing test: optimization of the index of circulating anticoagulant cut-off value.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
Clin Lab; 2014; 60(12):2115-8. PubMed ID: 25651752
[No Abstract] [Full Text] [Related]
19. Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines.
Talon L; Fourneyron V; Senectaire S; Tardieu M; Tillier M; Trapani A; Trayaud A; Vaissade A; Sapin AF; Lebreton A; Sinegre T
Thromb Res; 2023 Apr; 224():38-45. PubMed ID: 36827954
[TBL] [Abstract][Full Text] [Related]
20. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
